Rubicon Appoints New CEO; Begins Rolling Out Genome-Amplification Technology | GenomeWeb

NEW YORK, Sept. 4 - Rubicon Genomics' newly appointed president and CEO--the company's second in 20 months--said his first priority is to launch the firm's whole-genome amplification technology.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.